Low ANXA10 expression is associated with disease aggressiveness in bladder cancer

BACKGROUND: Markers for outcome prediction in bladder cancer are urgently needed. We have previously identified a molecular signature for predicting progression in non-muscle-invasive bladder cancer. ANXA10 was one of the markers included in the signature and we now validated the prognostic relevanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Munksgaard, P P, Mansilla, F, Brems Eskildsen, A-S, Fristrup, N, Birkenkamp-Demtröder, K, Ulhøi, B P, Borre, M, Agerbæk, M, Hermann, G G, Ørntoft, T F, Dyrskjøt, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241563/
https://www.ncbi.nlm.nih.gov/pubmed/21979422
http://dx.doi.org/10.1038/bjc.2011.404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3241563/
https://www.ncbi.nlm.nih.gov/pubmed/21979422
http://dx.doi.org/10.1038/bjc.2011.404

Ejemplares similares